Search results for "portion"

showing 10 items of 902 documents

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies

2019

[Background]: The pandemic of cardiovascular disease (CVD) and type 2 diabetes (T2D) requires the identification of new predictor biomarkers. Biomarkers potentially modifiable with lifestyle changes deserve a special interest. Our aims were to analyze: (a) The associations of lysine, 2-aminoadipic acid (2-AAA) or pipecolic acid with the risk of T2D or CVD in the PREDIMED trial; (b) the effect of the dietary intervention on 1-year changes in these metabolites, and (c) whether the Mediterranean diet (MedDiet) interventions can modify the effects of these metabolites on CVD or T2D risk. [Methods]: Two unstratified case-cohort studies nested within the PREDIMED trial were used. For CVD analyses…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemTime FactorsMediterranean dietEndocrinology Diabetes and MetabolismhumanosDiseaseType 2 diabetes030204 cardiovascular system & hematologyDiet Mediterraneanchemistry.chemical_compound0302 clinical medicineRisk Factorsestudios prospectivosevaluación de riesgosMetabolites030212 general & internal medicineProspective Studiesmediana edadOriginal InvestigationPipecolic acidRandomized Controlled Trials as TopicAged 80 and overancianodietaácidos pipecólicosensayos clínicos controlados aleatorizados como asuntoresultado del tratamientoIncidenceType 2 diabetesMiddle AgedCardiovascular disease3. Good healthPrimary PreventionTreatment OutcomeCardiovascular DiseasesPipecolic AcidsFemaleCardiology and Cardiovascular Medicineconducta de reducción del riesgoCohort studymedicine.medical_specialtyenfermedades cardiovascularesácido 2-aminoadípicoRisk Assessmentincidencia03 medical and health sciencesfactores de tiempoInternal medicineDiabetes mellitusmedicineDiabetes Mellitusfactores de riesgoHumansAngiologyAgedProportional hazards modelbusiness.industryLysinemedicine.diseaseDietlisinaDietary interventionchemistryDiabetes Mellitus Type 2lcsh:RC666-701business2-Aminoadipic AcidRisk Reduction BehaviorBiomarkers
researchProduct

Prognostic Value of Pulmonary Vascular Resistance by Magnetic Resonance in Systolic Heart Failure

2016

Abstract Background: Pulmonary hypertension is associated with poor prognosis in heart failure. However, non-invasive diagnosis is still challenging in clinical practice. Objective: We sought to assess the prognostic utility of non-invasive estimation of pulmonary vascular resistances (PVR) by cardiovascular magnetic resonance to predict adverse cardiovascular outcomes in heart failure with reduced ejection fraction (HFrEF). Methods: Prospective registry of patients with left ventricular ejection fraction (LVEF) < 40% and recently admitted for decompensated heart failure during three years. PVRwere calculated based on right ventricular ejection fraction and average velocity of the pulmonary…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyMagnetic Resonance SpectroscopyHypertension PulmonaryPrognósticoInsuficiência CardíacaMagnetic Resonance Imaging Cine030204 cardiovascular system & hematology03 medical and health sciencesCardiovascular Magnetic Resonance Imaging0302 clinical medicinePredictive Value of Testsmedicine.arteryInternal medicinemedicineHumansProspective Studies030212 general & internal medicineAgedHeart FailureEjection fractionbusiness.industryProportional hazards modelStroke VolumeOriginal ArticlesStroke volumeMiddle AgedPrognosismedicine.diseaseSurvival AnalysisPulmonary hypertensionmedicine.anatomical_structurelcsh:RC666-701Predictive value of testsHeart failurePulmonary arteryVascular resistanceCardiologyFemaleVascular ResistanceResistência VascularCardiology and Cardiovascular MedicinebusinessHipertensão PulmonarEspectroscopia de Ressonância MagnéticaHeart Failure SystolicArquivos Brasileiros de Cardiologia
researchProduct

Performance in dynamic movement tasks and occurrence of low back pain in youth floorball and basketball players

2020

Abstract Background Prospective studies investigating risk factors for low back pain (LBP) in youth athletes are limited. The aim of this prospective study was to investigate the association between hip-pelvic kinematics and vertical ground reaction force (vGRF) during landing tasks and LBP in youth floorball and basketball players. Methods Three-hundred-and-eighty-three Finnish youth female and male floorball and basketball players (mean age 15.7 ± 1.8) participated and were followed up on for 3 years. At the beginning of every study year the players were tested with a single-leg vertical drop jump (SLVDJ) and a vertical drop jump (VDJ). Hip-pelvic kinematics, measured as femur-pelvic angl…

Malelcsh:Diseases of the musculoskeletal systemSports medicinemedicine.medical_treatment0302 clinical medicinenuoretrisk factorsOrthopedics and Sports MedicineProspective Studies315 Sport and fitness sciencesRange of Motion ArticularProspective cohort studylow back painFinlandRehabilitationbiologylumbar spineriskitekijätLow back painBiomechanical Phenomenayouth athletes.Lumbar spineLower ExtremityCohortselkäFemalebiomekaniikkateam sportsmedicine.symptomResearch Articlemedicine.medical_specialtyBasketballAdolescentBasketballPelvis03 medical and health sciencesPhysical medicine and rehabilitationselkärankaRheumatologymedicineHumansjoukkueurheiluLow back painYouth athletesProportional Hazards ModelsHipAthletesbusiness.industrykipu030229 sport sciences3126 Surgery anesthesiology intensive care radiologybiology.organism_classificationbody regionsTeam sportsRisk factorsAthletesMixed effectslcsh:RC925-935business030217 neurology & neurosurgeryurheilijatBMC Musculoskeletal Disorders
researchProduct

Effect of weight loss on mortality in overweight and obese nursing home residents during a 5-year follow-up.

2015

Background/Objectives:The objective of this study was to ascertain the effect of weight loss over the course of 1 year on 5-year mortality in old nursing home (NH) residents in different classes of body mass index (BMI).Subjects/Methods:A longitudinal study was conducted on 161 NH residents aged ≥70 years at the Istituto di Riposo per Anziani, Padova, Italy. Data were collected using a comprehensive geriatric assessment at baseline and at a 1-year follow-up visit. Mortality was recorded over a 5-year follow-up. We divided our sample into four groups using as cutoffs a BMI of 25 and a weight gain or loss of 5% at 1 year (BMI ≥25 and weight stable/gain, BMI ≥25 and weight loss, BMI&lt;25 and …

Malemedicine.medical_specialtyActivities of daily livingMedicine (miscellaneous)Nutritional StatusOverweightBody Mass IndexWeight lossRisk FactorsActivities of Daily LivingWeight LossmedicineHomes for the AgedHumansLongitudinal StudiesObesityAgedProportional Hazards ModelsAged 80 and overNutrition and Dieteticsbusiness.industryProportional hazards modelOverweightmedicine.diseaseObesitybody massNursing HomesItalyPhysical therapyFemalemedicine.symptombusinessNursing homesWeight gainBody mass indexDemographyFollow-Up Studies
researchProduct

Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain.

2016

Background The endogenous amino acid homoarginine predicts mortality in cerebro‐ and cardiovascular disease. The objective was to explore whether homoarginine is associated with atrial fibrillation ( AF ) and outcome in patients with acute chest pain. Methods and Results One thousand six hundred forty‐nine patients with acute chest pain were consecutively enrolled in this study, of whom 589 were diagnosed acute coronary syndrome ( ACS ). On admission, plasma concentrations of homoarginine as well as brain natriuretic peptide ( BNP ), and high‐sensitivity assayed troponin I (hsTnI) were determined along with electrocardiography ( ECG ) variables. During a median follow‐up of 183 days, 60 ma…

Malemedicine.medical_specialtyAcute coronary syndromeChest PainMyocardial InfarctionKaplan-Meier Estimate030204 cardiovascular system & hematologyChest painacute coronary syndrome03 medical and health sciences0302 clinical medicineInternal medicineTroponin IAtrial FibrillationNatriuretic Peptide BrainmedicineHumansCoronary Heart Disease030212 general & internal medicineMyocardial infarctionddc:610AgedProportional Hazards ModelsOriginal Researchbusiness.industryHazard ratioAtrial fibrillationMiddle Agedmedicine.diseaseBrain natriuretic peptidePrognosisAcute PainHomoarginine3. Good healthSurgeryStrokel‐arginine:glycine amidinotransferaseCardiologyEndothelium/Vascular Type/Nitric OxideFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessAcute Coronary SyndromesMaceBiomarkersJournal of the American Heart Association
researchProduct

Mitral Regurgitation and Prognosis After Non-ST-Segment Elevation Myocardial Infarction in Very Old Patients.

2019

Background/Objetctives: Mitral regurgitation (MR)after an acute coronary syndrome is associated with a poor prognosis. However,the prognostic impact of MR in elderly patients with non-ST-segment elevation myocardialinfarction (NSTEMI) has not been well addressed. Design: Prospective registry. Setting And Participants: The multicenter LONGEVO-SCA prospective registry included 532 unselected NSTEMI patients aged ≥80 years. Measurements: MR was quantified using echocardiography during admission in 497 patients. They were classified in two groups: significant (moderate or severe) or not significant MR (absent or mild). We evaluated the impact of MR status on mortality or readmission at 6 months…

Malemedicine.medical_specialtyAcute coronary syndromeEnfermedad cardiovascularAnciano030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineST segmentHumans030212 general & internal medicineMyocardial infarctionHospital MortalityProspective StudiesRegistriesNon-ST Elevated Myocardial InfarctionKillip classProportional Hazards ModelsAged 80 and overEjection fractionbusiness.industryHazard ratioMitral Valve InsufficiencyLength of Staymedicine.diseasePrognosisConfidence intervalGeriatríaBlood pressureEchocardiographyCardiologyVálvulas cardíacasFemaleGeriatrics and GerontologyInfarto de miocardiobusinessJournal of the American Geriatrics Society
researchProduct

Relation of Low Lymphocyte Count to Frailty and its Usefulness as a Prognostic Biomarker in Patients &gt;65 Years of Age With Acute Coronary Syndrome

2020

Low lymphocyte count, as a marker of inflammation and immunosuppression, may be useful for identifying frail patients. In this work, we aimed to evaluate the association between low-relative lymphocyte count (Lymph%) and frailty status in patients >65 years old with acute coronary syndromes (ACS), and whether Lymph% is associated with morbimortality beyond standard prognosticators and frailty. In this prospective observational study, we included 488 hospital survivors of an episode of an ACS >65 years old. Total and differential white blood cells and frailty status were assessed at discharge. Frailty was evaluated using the Fried score at discharge and defined as Fried≥3. The independent as…

Malemedicine.medical_specialtyAcute coronary syndromeMultivariate analysisLymphocytemedicine.medical_treatment030204 cardiovascular system & hematologyLogistic regression03 medical and health sciences0302 clinical medicineRisk FactorsInterquartile rangeInternal medicinemedicineHumansLymphocyte CountProspective Studies030212 general & internal medicineAcute Coronary SyndromeGeriatric AssessmentAgedFrailtyProportional hazards modelbusiness.industryImmunosuppressionPrognosismedicine.diseaseSurvival Ratemedicine.anatomical_structureSpainCardiologyFemaleLymphCardiology and Cardiovascular MedicinebusinessBiomarkersThe American Journal of Cardiology
researchProduct

Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome.

2019

Background The Charlson's is the most used comorbidity index. It comprises 19 comorbidities, some of which are infrequent in elderly patients with acute coronary syndrome (ACS), while some others are manifestations of cardiac disease rather than comorbidities. Our goal was to simplify comorbidity assessment in elderly non-ST-segment elevation ACS patients. Methods The study group consisted of 1 training (n = 920, 76 ± 7 years) and 1 testing (n = 532; 84 ± 4 years) cohorts. The end-point was all-cause mortality at 1-year follow-up. Comorbidities were assessed selecting those medical disorders other than cardiac disease that were independently associated with mortality by multivariable analys…

Malemedicine.medical_specialtyAcute coronary syndromeTime FactorsAnemiaEnfermedad cardiovascularAncianoCharlson indexDiseaseComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusCause of Deathmental disordersInternal MedicinemedicineHumans030212 general & internal medicineHospital MortalityProspective StudiesAcute Coronary SyndromeAgedProportional Hazards ModelsAged 80 and overbusiness.industrymedicine.diseaseComorbiditySpainRisk stratificationCohortCardiopatía coronariaFemalebusinessAncianosEuropean journal of internal medicine
researchProduct

Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the A…

2007

Summary. Background: Tissue factor (TF) and its specific inhibitor, tissue factor pathway inhibitor (TFPI), are important contributors to the initiation of the coagulation process. Objectives: To compare plasma levels of soluble TF (sTF) and free-TFPI (f-TFPI) between patients with stable angina pectoris (SAP) and acute coronary syndrome (ACS) and to assess the impact of the two variables on long-term prognosis. Patients/methods: Patients with SAPs (n = 1146) and acute coronary syndrome (n = 523) from the AtheroGene study were included and followed for 2.3 years. Because of the strong impact of unfractionated heparin (UFH) on f-TFPI levels, but not on sTF levels, patients having received UF…

Malemedicine.medical_specialtyAcute coronary syndromeTime FactorsLipoproteinsMyocardial InfarctionRisk AssessmentSeverity of Illness IndexAngina PectorisThromboplastinCoronary artery diseaseCohort StudiesTissue factor pathway inhibitorPredictive Value of TestsInternal medicineGermanymedicineHumansMyocardial infarctionProspective StudiesAgedProportional Hazards ModelsUnstable anginabusiness.industryHazard ratioCoronary StenosisHematologySyndromeMiddle Agedmedicine.diseasePrognosisThrombosisCardiovascular DiseasesCardiologyFemalebusinessBiomarkersBlood drawingFollow-Up StudiesJournal of thrombosis and haemostasis : JTH
researchProduct

Sex-differential effect of frailty on long-term mortality in elderly patients after an acute coronary syndrome.

2020

Background The potential sex-differential effect of frailty in patients with acute coronary syndromes (ACS) has not been well-evaluated. We sought to examine the sex-differential association between frailty status on long-term mortality in elderly patients with an ACS. Methods and results This is a prospective observational single-center study that included 488 elderly patients (>65 years) hospitalized for ACS who survived the index hospitalization. Multivariate Cox regression was used to determine the association among the exposures (interaction of sex with Fried score and sex with Fried ≥ 3) and all-cause mortality. The mean age of the sample was 78 ± 7 years; 41% were female and the medi…

Malemedicine.medical_specialtyAcute coronary syndromeTime Factorsfrailty030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineSex FactorsInternal medicinemedicineHumansacute coronary syndromesIn patient030212 general & internal medicineProspective StudiesAcute Coronary SyndromeSex DistributionAgedFrailtyProportional hazards modelbusiness.industryIncidenceAge FactorsMean agemedicine.diseasePrognosisSurvival RateSpainLong term mortalityObservational studyFemalewomenprognosisCardiology and Cardiovascular MedicinebusinessIndex hospitalizationFollow-Up StudiesInternational journal of cardiology
researchProduct